BioXcel Therapeutics (BTAI) Return on Sales Growth (1y) (2023 - 2026)
BioXcel Therapeutics (BTAI) Return on Sales Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 0.00 |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 0.00 |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 0.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 0.00 |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 0.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 0.00 |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 0.00 |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.40 Mn | 24.40 Mn | 160,000.00 | 87.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 87.00 |
| Mar 31, 2026 | 13.00 |
| Dec 31, 2025 | -8.00 |
| Sep 30, 2025 | -97.00 |
| Jun 30, 2025 | -147.00 |
| Mar 31, 2025 | -36.00 |
| Dec 31, 2024 | 36.00 |
| Sep 30, 2024 | 74.00 |
| Jun 30, 2024 | 113.00 |
| Mar 31, 2024 | 368.00 |
| Dec 31, 2023 | 658.00 |
| Sep 30, 2023 | 267.00 |